2024
Psychotropic Drugs Reemerging as Headache Medicines
Schindler E. Psychotropic Drugs Reemerging as Headache Medicines. CNS Drugs 2024, 38: 661-670. PMID: 39037675, DOI: 10.1007/s40263-024-01107-x.Peer-Reviewed Original ResearchManaging Cluster Headache in Patients with Medical, Psychiatric, and Surgical Comorbidities
Burish M, Guirguis A, Schindler E. Managing Cluster Headache in Patients with Medical, Psychiatric, and Surgical Comorbidities. Current Neurology And Neuroscience Reports 2024, 24: 439-452. PMID: 39017830, DOI: 10.1007/s11910-024-01362-x.Peer-Reviewed Original Research
2023
Adapting psychedelic medicine for headache and chronic pain disorders
Schindler E, Hendricks P. Adapting psychedelic medicine for headache and chronic pain disorders. Expert Review Of Neurotherapeutics 2023, 23: 867-882. PMID: 37652000, DOI: 10.1080/14737175.2023.2246655.Peer-Reviewed Original ResearchConceptsChronic pain disordersPain disordersHeadache disordersChronic pain patientsRecent case reportsDifferent treatment paradigmsPsychedelic medicineSubstance use disordersMechanism of actionPain patientsChronic painCase reportClinical trialsTreatment paradigmTreatment outcomesTherapeutic effectLarge dosesUse disordersAdjunctive psychotherapyTherapeutic outcomesHeadacheBeneficial effectsSubjective effectsBranches of medicineDisordersThe Potential of Psychedelics for the Treatment of Episodic Migraine
Schindler E. The Potential of Psychedelics for the Treatment of Episodic Migraine. Current Pain And Headache Reports 2023, 27: 489-495. PMID: 37540398, DOI: 10.1007/s11916-023-01145-y.Peer-Reviewed Original ResearchConceptsEpisodic migrainePotential of psychedelicsWeekly migraine daysPsychedelic drugsMigraine daysPain intensityTransitional treatmentCluster headacheHeadache disordersPreventive effectClinical trialsSingle administrationTherapeutic effectAbortive effectMigrainePsychiatric conditionsReviewThis reviewTherapeutic agentsDrugsAdditional findingsMedicinal usePsychedelicsTreatmentPotential medicinal usePsilocybin